Practice
Open Access
Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation
Brittany Salter, Matthew Jessome, Mark Tarnopolsky and Haroon Yousuf
CMAJ February 22, 2022 194 (7) E252-E256; DOI: https://doi.org/10.1503/cmaj.211856
Brittany Salter
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
MD PhDMatthew Jessome
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
MDMark Tarnopolsky
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
MDHaroon Yousuf
Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
MDRelated Articles
- Salter, B., Jessome, M., Tarnopolsky, M., & Yousuf, H. (2022). Lien possible entre rhabdomyolyse et vaccin anti-SRAS-CoV-2 à ARNm chez une patiente porteuse d’une mutation du gène RYR1. CMAJ, 194(12), E473-E478. Accessed April 17, 2024. https://doi.org/10.1503/cmaj.211856-f.
- Blais, A. (2022). Succinylcholine, malignant hyperthermia and rhabdomyolysis. CMAJ, 194(25), E878. Accessed April 17, 2024. https://doi.org/10.1503/cmaj.146480-l.
In this issue
Article tools
Respond to this article
Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation
Brittany Salter, Matthew Jessome, Mark Tarnopolsky, Haroon Yousuf
CMAJ Feb 2022, 194 (7) E252-E256; DOI: 10.1503/cmaj.211856